/

Empresas

Cy

No verificado

Cyllene Therapeutics

Sobre qué escribimos

Anuncios brevesFinanzas

3 Comunicados de prensa

Ver todos los comunicados de prensa

22/07/2026

Anuncios breves

Cyllene Therapeutics Expands Leadership Team to Support Corporate Growth and Clinical Product Development

Fuente

Cyllene Therapeutics

Editor

1.00

0

06/07/2026

Finanzas

Cyllene Therapeutics (anciennement EG427) lève 33 millions d’euros lors d’une Série C pour accélérer le développement clinique d’EG110A et l’expansion de son pipeline

Fuente

Cyllene Therapeutics

Editor

1.00

0

06/07/2026

Finanzas

Cyllene Therapeutics (formerly known as EG 427) Raises €33 Million Series C Financing to Advance Clinical Development of EG110A and Pipeline Expansion

Fuente

Cyllene Therapeutics

Editor

1.00

0

Seguidores

0

Compatibilidad

0